FDA together with Claris Lifesciences announced the voluntary nationwide recall of Ciprofloxacin due to risk of contamination related to the packaging of the product. The recall was issued as a precautionary measure.
The recalled products include:
- Ciprofloxacin Inj. USP 200 mg / 100 mL (NDC 36000-008-24),
- Ciprofloxacin Inj. USP 400 mg / 200 mL (NDC 36000-009-24),
- Metronidazole Inj. USP 500 mg/100 ml (NDC 36000-001-24), and
- Ondansetron in 5% Dextrose Inj. 32 mg / 50 mL (36000-014-06)
All of the recalled products were manufactured and distributed by Claris Lifesciences. The medicines were distributed to hospitals, wholesalers and other distributors within the US.
FDA advises healthcare professionals to stop using these products and to remove them from their pharmacy inventories.
Claris has initiating the recall after receiving reports of floating matter in the products which may pose risk if administered to patients. There haven’t been any reports of injuries related to the recalled products so far.
